Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MGLL | Q99685 | 10/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | FABP7 | O15540 | 1/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16860005 | 0.82 | POLB (0.56) | POLBL3MBTL1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL7071938 | 0.80 | CYP3A4 (0.51) | MGLLKMT2AHTTSMN1; SMN2MTNR1A | |
| SCHEMBL7070749 | 0.78 | SMN1; SMN2 (0.50) | KMT2ASMN1; SMN2TDP1 | |
| SCHEMBL7073822 | 0.76 | ELANE (0.50) | POLBMGLLSMN1; SMN2ELANE | |
| SCHEMBL7075614 | 0.76 | MGLL (0.47) | MGLLKMT2AELANEMTNR1B | |
| SCHEMBL28237429 | 0.76 | KMT2A (0.61) | POLBMGLLL3MBTL1KMT2AHTT | |
| SCHEMBL7072557 | 0.75 | PDE4A (0.50) | KMT2ASMN1; SMN2 | |
| SCHEMBL7069974 | 0.75 | PDE4A (0.50) | KMT2ASMN1; SMN2 | |
| SCHEMBL7074165 | 0.75 | KMT2A (0.48) | POLBKMT2AHTTSMN1; SMN2TDP1 | |
| SCHEMBL11035516 | 0.74 | MGLL (0.45) | POLBMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | BAYER CROPSCIENCE LIMITED (GB) | 2003-09-25 | — | — | US | disclosed |
| WO-2003051119-A1 | NEW HERBICIDAL COMPOUNDS AND METHOD | BAYER CROPSCIENCE LIMITED (GB) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | DDT, HAAO, CYP4X1 | POLB 2176/4885MGLL 1008/4885L3MBTL1 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.